[EN] GLYCOSPHINGOLIPIDS FOR USE IN MODULATING IMMUNE RESPONSES<br/>[FR] GLYCOSPHINGOLIPIDES UTILES À LA MODULATION DES RÉPONSES IMMUNITAIRES
申请人:UNIV CALIFORNIA
公开号:WO2013119857A1
公开(公告)日:2013-08-15
Provided herein are sphingolipid compounds that are useful for activating natural killer T cells. Also provided are methods for treating or preventing a disease or disorder that is treatable by activating the immune system by stimulating natural killer T cells. The compounds are therefore useful for treating or reducing the likelihood of occurrence of an immune diseases and disorders, such as autoimmune diseases or disorders. The compounds may also be used for treating or reducing the likelihood of occurrence of a microbial infection or for treating or reducing the likelihood of occurrence of a cancer in a subject by administering the sphingolipid compounds described herein.
Glycosphingolipids for use in modulating immune responses
申请人:The Regents of the University of California
公开号:US10227290B2
公开(公告)日:2019-03-12
Provided herein are sphingolipid compounds that are useful for activating natural killer T cells. Also provided are methods for treating or preventing a disease or disorder that is treatable by activating the immune system by stimulating natural killer T cells. The compounds are therefore useful for treating or reducing the likelihood of occurrence of an immune diseases and disorders, such as autoimmune diseases or disorders. The compounds may also be used for treating or reducing the likelihood of occurrence of a microbial infection or for treating or reducing the likelihood of occurrence of a cancer in a subject by administering the sphingolipid compounds described herein.
本文提供了可用于激活自然杀伤 T 细胞的鞘脂化合物。还提供了治疗或预防可通过刺激自然杀伤 T 细胞激活免疫系统来治疗的疾病或紊乱的方法。因此,这些化合物可用于治疗或降低免疫性疾病和失调(如自身免疫性疾病或失调)发生的可能性。这些化合物还可用于治疗或降低微生物感染发生的可能性,或通过施用本文所述的鞘脂化合物治疗或降低受试者癌症发生的可能性。
GLYCOSPHINGOLIPIDS FOR USE IN MODULATING IMMUNE RESPONSES
申请人:The Regents of the University of California
公开号:US20140377291A1
公开(公告)日:2014-12-25
Provided herein are sphingolipid compounds that are useful for activating natural killer T cells. Also provided are methods for treating or preventing a disease or disorder that is treatable by activating the immune system by stimulating natural killer T cells. The compounds are therefore useful for treating or reducing the likelihood of occurrence of an immune diseases and disorders, such as autoimmune diseases or disorders. The compounds may also be used for treating or reducing the likelihood of occurrence of a microbial infection or for treating or reducing the likelihood of occurrence of a cancer in a subject by administering the sphingolipid compounds described herein.
Structure and conserved function of iso-branched sphingoid bases from the nematode Caenorhabditis elegans
作者:J. Thomas Hannich、Denia Mellal、Suihan Feng、Andreas Zumbuehl、Howard Riezman
DOI:10.1039/c6sc04831e
日期:——
Nematode-specific iso-branched sphingoid base synthesis: drug-target against parasites and genetic model system for human diseases.